This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Taskinen, P. Articles by Ruskoaho, H. Search for Related Content PubMed PubMed Citation Articles by Taskinen, P. Articles by Ruskoaho, H.

Inhibition of Atrial Wall Stretch-Induced Cardiac Hormone Secretion by Lavendustin A, a Potent Tyrosine Kinase Inhibitor¹

Departments of Pharmacology and Toxicology and Physiology (O.V), Biocenter Oulu, University of Oulu, 90401 Oulu, Finland; and Department of Cardiovascular Surgery and First Department of Internal Medicine (M.T), Semmelwies University Medical School, 1102 Budapest, Hungary

Address all correspondence and requests for reprints to: Heikki Ruskoaho, M.D, Ph.D., Department of Pharmacology and Toxicology, University of Oulu, P.O. Box 5000, 90401 Oulu, Finland. E-mail: heikki.ruskoaho{at}.oulu.fi

The cellular processes linking mechanical wall stretch to atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) secretion from the heart are unclear. In the present study, a paced perfused rat heart preparation was used to study the signaling mechanisms of atrial wall stretch-induced secretion of ANP and BNP. Vehicle or drugs were infused into the perfusate for 40 min and right atrial wall stretch was superimposed for 10 min after 25-min drug infusions by elevating the level of the pulmonary artery cannula tip. Lavendustin A, a potent inhibitor of protein tyrosine kinases, at the concentrations of 0.5 and 1.3 µM decreased atrial wall stretch-induced ANP secretion (53% and 68%, respectively, P < 0.001) in the perfused rat heart preparation, whereas no difference in the hemodynamic variables (heart rate, contractile force and perfusion pressure) were noted between groups. Lavendustin A also completely abolished the wall stretch-induced secretion of BNP. Several other protein kinase inhibitors including staurosporine (protein kinase C inhibitor), ML-9 (myosin light chain kinase inhibitor), KN-62 (Ca²⁺/calmodulin-dependent protein kinase II inhibitor) and H-89 (protein kinase A inhibitor) had no significant effect on atrial wall stretch-stimulated ANP secretion. In a separate series of experiments, in which the right atria were stretched for 2 h, administration of lavendustin A (1 µM) but not staurosporine (30 nM) significantly decreased sustained wall stretch-induced ANP secretion. Okadaic acid, a potent protein phosphatase A2 (PPA2) and PP1 inhibitor, at the concentration of 100 nM had no effect on basal ANP secretion but significantly accelerated the ANP secretory response to atrial wall stretch (P < 0.05). In conclusion, the findings that inhibitors of protein tyrosine kinase and protein phosphatase selectively modulated atrial wall stretch-induced ANP secretion suggest a new mechanism involving endogenous protein tyrosine activity in the regulation of natriuretic peptide exocytosis from cardiac myocytes.

This article has been cited by other articles:

				J. R. Dietz Mechanisms of atrial natriuretic peptide secretion from the atrium Cardiovasc Res, October 1, 2005; 68(1): 8 - 17. [Abstract] [Full Text] [PDF]

				G. Apodaca Modulation of membrane traffic by mechanical stimuli Am J Physiol Renal Physiol, February 1, 2002; 282(2): F179 - F190. [Abstract] [Full Text] [PDF]